The Chemours Company (NYSE:CC) Receives $24.60 Average PT from Analysts

Shares of The Chemours Company (NYSE:CC) have earned a consensus rating of “Hold” from the twelve brokerages that are covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, five have assigned a hold rating and six have issued a buy rating on the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $24.60.

A number of equities analysts recently commented on the stock. JPMorgan Chase & Co. lifted their price target on shares of Chemours from $17.00 to $22.00 and gave the stock a “neutral” rating in a research note on Thursday, May 21st. Jefferies Financial Group reaffirmed a “hold” rating and set a $17.00 price target on shares of Chemours in a research note on Monday, February 23rd. Royal Bank Of Canada lifted their price target on shares of Chemours from $26.00 to $29.00 and gave the stock an “outperform” rating in a research note on Monday, May 11th. Alembic Global Advisors reaffirmed an “overweight” rating and set a $30.00 price target on shares of Chemours in a research note on Wednesday, May 13th. Finally, UBS Group lifted their price objective on shares of Chemours from $29.00 to $30.00 and gave the company a “buy” rating in a report on Friday, May 8th.

Institutional Investors Weigh In On Chemours

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CC. Parallel Advisors LLC raised its holdings in shares of Chemours by 10.9% in the 1st quarter. Parallel Advisors LLC now owns 5,366 shares of the specialty chemicals company’s stock valued at $118,000 after purchasing an additional 527 shares in the last quarter. Oregon Public Employees Retirement Fund raised its holdings in shares of Chemours by 1.8% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 34,300 shares of the specialty chemicals company’s stock valued at $404,000 after purchasing an additional 600 shares in the last quarter. PFG Investments LLC raised its holdings in shares of Chemours by 7.6% in the 4th quarter. PFG Investments LLC now owns 12,494 shares of the specialty chemicals company’s stock valued at $147,000 after purchasing an additional 883 shares in the last quarter. State of Alaska Department of Revenue raised its holdings in shares of Chemours by 1.2% in the 4th quarter. State of Alaska Department of Revenue now owns 76,257 shares of the specialty chemicals company’s stock valued at $899,000 after purchasing an additional 932 shares in the last quarter. Finally, Man Group plc raised its holdings in shares of Chemours by 0.4% in the 2nd quarter. Man Group plc now owns 271,108 shares of the specialty chemicals company’s stock valued at $3,104,000 after purchasing an additional 979 shares in the last quarter. Institutional investors own 76.26% of the company’s stock.

Chemours Price Performance

CC stock opened at $22.05 on Friday. Chemours has a 12 month low of $10.14 and a 12 month high of $28.67. The company has a current ratio of 1.82, a quick ratio of 0.87 and a debt-to-equity ratio of 18.98. The company has a 50-day moving average price of $23.05 and a 200 day moving average price of $18.37. The stock has a market cap of $3.32 billion, a PE ratio of -8.35 and a beta of 1.39.

Chemours (NYSE:CC) last released its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.10. Chemours had a negative net margin of 6.82% and a positive return on equity of 52.49%. The firm had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.40 billion. During the same period in the previous year, the company earned $0.13 EPS. The firm’s revenue for the quarter was up 1.0% compared to the same quarter last year. Equities research analysts anticipate that Chemours will post 1.07 earnings per share for the current year.

Chemours Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Sunday, May 17th will be issued a dividend of $0.0875 per share. The ex-dividend date is Friday, May 15th. This represents a $0.35 dividend on an annualized basis and a yield of 1.6%. Chemours’s dividend payout ratio (DPR) is presently -13.26%.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.